Merck & Company
(MRK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,934,000 | 4,517,000 | 6,299,000 | 6,392,000 | 982,000 |
| Depreciation Amortization | 6,691,000 | 6,988,000 | 6,978,000 | 7,427,000 | 7,381,000 |
| Income taxes - deferred | -2,600,000 | -330,000 | 669,000 | -1,537,000 | -1,092,000 |
| Accounts receivable | -554,000 | 436,000 | 349,000 | -1,168,000 | -1,089,000 |
| Accounts payable and accrued liabilities | 593,000 | 522,000 | -302,000 | 182,000 | 124,000 |
| Other Working Capital | 1,824,000 | -794,000 | -4,136,000 | -766,000 | 930,000 |
| Other Operating Activity | -9,899,000 | 315,000 | 165,000 | 1,853,000 | 3,586,000 |
| Operating Cash Flow | $7,989,000 | $11,654,000 | $10,022,000 | $12,383,000 | $10,822,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,830,000 | -1,693,000 | -5,058,000 | -1,176,000 | -2,636,000 |
| PPE Investments | -1,317,000 | -1,548,000 | -1,954,000 | -1,723,000 | -1,678,000 |
| Net Acquisitions | 11,239,000 | -200,000 | N/A | -50,000 | -256,000 |
| Purchase Sale Intangibles | -1,000,000 | 0 | N/A | N/A | N/A |
| Other Investing Activity | -466,000 | 293,000 | 207,000 | 59,000 | 1,073,000 |
| Investing Cash Flow | $-374,000 | $-3,148,000 | $-6,805,000 | $-2,890,000 | $-3,497,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -460,000 | -159,000 | 624,000 | 1,076,000 | 90,000 |
| Debt Issued | 3,146,000 | 6,467,000 | 2,562,000 | 0 | 1,999,000 |
| Debt Repayment | -6,617,000 | -1,775,000 | -22,000 | -1,547,000 | -1,341,000 |
| Common Stock Issued | 1,560,000 | 1,210,000 | 1,310,000 | 321,000 | 363,000 |
| Common Stock Repurchased | -7,703,000 | -6,516,000 | -2,591,000 | -1,921,000 | -1,593,000 |
| Dividend Paid | -5,247,000 | -5,277,000 | -5,236,000 | -4,811,000 | -4,853,000 |
| Other Financing Activity | 79,000 | 60,000 | 86,000 | -22,000 | -106,000 |
| Financing Cash Flow | $-15,242,000 | $-5,990,000 | $-3,267,000 | $-6,904,000 | $-5,441,000 |
| Exchange Rate Effect | -553,000 | -346,000 | -30,000 | 42,000 | -295,000 |
| Beginning Cash Position | 15,621,000 | 13,451,000 | 13,531,000 | 10,900,000 | 9,311,000 |
| End Cash Position | 7,441,000 | 15,621,000 | 13,451,000 | 13,531,000 | 10,900,000 |
| Net Cash Flow | $-8,180,000 | $2,170,000 | $-80,000 | $2,631,000 | $1,589,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,989,000 | 11,654,000 | 10,022,000 | 12,383,000 | 10,822,000 |
| Capital Expenditure | -1,317,000 | -1,548,000 | -1,954,000 | -1,723,000 | -1,678,000 |
| Free Cash Flow | 6,672,000 | 10,106,000 | 8,068,000 | 10,660,000 | 9,144,000 |